Fu Yi-Peng, Yi Yong, Huang Jin-Long, Jing Chu-Yu, Sun Jian, Ni Xiao-Chun, Lu Zhu-Feng, Cao Ya, Zhou Jian, Fan Jia, Qiu Shuang-Jian
Liver Cancer Institute, Zhongshan Hospital and Shanghai Medical School, Fudan University, Key Laboratory for Carcinogenesis & Cancer Invasion, The Chinese Ministry of Education, Shanghai, People's Republic of China.
Cancer Research Institute, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Oncologist. 2017 May;22(5):561-569. doi: 10.1634/theoncologist.2016-0231. Epub 2017 Apr 24.
The prognosis of patients with hepatocellular carcinoma (HCC) without portal vein tumor thrombosis (PVTT) after curative resection is at variance. We identified the risk factors of poor postoperative prognosis and consequently developed prognostic nomograms generating individual risk of death and recurrence for this subgroup of patients with HCC.
The risk factors were identified and nomograms were developed based on a retrospective study of 734 patients in the primary cohort who underwent curative resection for HCC from 2010 to 2012. The predictive accuracy and discriminative ability of the nomograms were determined by concordance index (C-index) and calibration curve and compared with traditional staging systems of HCC. The results were validated in an independent cohort of 349 patients operated at the same institution in 2007.
All of the independent factors for survival in multivariate analysis in the primary cohort were selected into the nomograms. The calibration curve for probability of survival showed good agreement between prediction by nomograms and actual observation. The C-indices of the nomograms for predicting overall survival and recurrence-free survival were 0.755 (95% confidence interval [CI], 0.752-0.758) and 0.665 (95% CI, 0.662-0.668), respectively, which were statistically higher than the C-indices of other HCC prognostic models. The results were further confirmed in the validation cohort.
The proposed nomograms resulted in more accurate prognostic prediction for patients with HCC without PVTT after curative resection. 2017;22:561-569 IMPLICATIONS FOR PRACTICE: Hepatocellular carcinoma (HCC) poses a great therapeutic challenge due to the poor prognosis in patients underwent surgical resection. The portal vein tumor thrombosis (PVTT) as a robust risk factor for survival has been routinely integrated to staging systems. Nonetheless, the prognosis stratification for patients without PVTT was neglected to some extent. Herein, independent risk factors of OS and RFS in HCC patients without PVTT were reconfirmed. A predictive nomogram was constructed on these risk factors and was demonstrated to be a more accurate predictive model in HCC patients without PVTT, compared with the traditional staging systems.
肝细胞癌(HCC)患者在根治性切除术后无门静脉癌栓(PVTT)时,其预后存在差异。我们确定了术后预后不良的危险因素,并据此为这一亚组HCC患者开发了预后列线图,以预测个体的死亡和复发风险。
基于对2010年至2012年期间接受HCC根治性切除的734例患者的回顾性研究,确定危险因素并绘制列线图。通过一致性指数(C指数)和校准曲线确定列线图的预测准确性和辨别能力,并与HCC的传统分期系统进行比较。结果在2007年于同一机构接受手术的349例独立队列患者中得到验证。
多因素分析中在主要队列中所有生存的独立因素均被纳入列线图。生存概率的校准曲线显示列线图预测与实际观察结果之间具有良好的一致性。预测总生存和无复发生存的列线图的C指数分别为0.755(95%置信区间[CI],0.752 - 0.758)和0.665(95%CI,0.662 - 0.668),在统计学上高于其他HCC预后模型的C指数。结果在验证队列中得到进一步证实。
所提出的列线图对根治性切除术后无PVTT的HCC患者的预后预测更为准确。2017;22:561 - 569对实践的启示:由于接受手术切除的患者预后较差,肝细胞癌(HCC)带来了巨大的治疗挑战。门静脉癌栓(PVTT)作为生存的一个重要危险因素已被常规纳入分期系统。然而,在一定程度上忽视了无PVTT患者的预后分层。在此,再次证实了无PVTT的HCC患者总生存(OS)和无复发生存(RFS)的独立危险因素。基于这些危险因素构建了预测列线图,与传统分期系统相比,该列线图在无PVTT的HCC患者中被证明是一个更准确的预测模型。